ArticleslgStudy

science

Macitentan/tadalafil

Macitentan/tadalafil is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Macitentan/tadalafil rather than just read about it. In short: Macitentan/tadalafil, sold under the brand name Opsynvi, is a fixed dose combination medication used for the treatment of pulmonary arterial hypertension. It contains macitentan, an endothelin receptor antagonist (ERA); and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor.

Key takeaways

  • Macitentan/tadalafil belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Macitentan/tadalafil to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Macitentan/tadalafil from memory before moving on to harder problems.

Reference excerpt

Macitentan/tadalafil, sold under the brand name Opsynvi, is a fixed dose combination medication used for the treatment of pulmonary arterial hypertension. It contains macitentan, an endothelin receptor antagonist (ERA); and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. Macitentan/tadalafil was approved for medical use in Canada in October 2021, in the United States in March 2024, and in the European Union in September 2024.

Medical uses Macitentan/tadalafil is indicated for the chronic treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adults of WHO functional class (FC) II-III.

Adverse effects Macitentan/tadalafil may cause harm to the fetus.

Society and culture

Legal status In July 2024, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Yuvanci, intended for the treatment of pulmonary arterial hypertension (PAH). The applicant for this medicinal product is Janssen-Cilag International NV. The combination was authorized for medical use in the European Union in September 2024.

References

External links Clinical trial number NCT03904693 for "Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) (A DUE)" at ClinicalTrials.gov

Worked examples

Example 1 — a first encounter with Macitentan/tadalafil

Start with the simplest possible case. Write down what Macitentan/tadalafil claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Macitentan/tadalafil before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Macitentan/tadalafil ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Macitentan/tadalafil

In research
Macitentan/tadalafil appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Macitentan/tadalafil in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Macitentan/tadalafil is common in secondary-school and first-year university syllabi. It links to neighbouring topics Drugs developed by Johnson & Johnson, Endothelin receptor antagonists, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life
Look for Macitentan/tadalafil outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Macitentan/tadalafil” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Macitentan/tadalafil in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Macitentan/tadalafil means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Macitentan/tadalafil out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Macitentan/tadalafil in simple terms?

Macitentan/tadalafil, sold under the brand name Opsynvi, is a fixed dose combination medication used for the treatment of pulmonary arterial hypertension. It contains macitentan, an endothelin receptor antagonist (ERA); and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor.

Why does Macitentan/tadalafil matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Macitentan/tadalafil?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Macitentan/tadalafil.

Tags

  • Drugs developed by Johnson & Johnson
  • Endothelin receptor antagonists
  • Orphan drugs
  • PDE5 inhibitors

Keep exploring